Myeloproliferative neoplasms: open trials in South Korea

10 open trials have a site in South Korea. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Busan · Jeollanam · Seoul · Uijeongbu-si
Registry updated 2026-11-09
NCT07357727
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Busan · Jeonju · Seoul · Suwon
Registry updated 2026-11-06
NCT07623161
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Trial Treatment · Phase 3 · Takeda
Daegu Catholic University Medical Center, Daegu · Seoul National University Bundang Hospital, Seongnam-si · Korea University Anam Hospital, Seoul · The Catholic University of Korea, Seoul · Soon Chun Hyang University Hospital Seoul, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul
Registry updated 2026-11-06
NCT07623200
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Trial Treatment · Phase 3 · Incyte Corporation
Pusan National University Hospital (PNUH), Busan · Seoul National University Bundang Hospital (SNUBH), Seongnam-si · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Korea University Anam Hospital, Seoul
Registry updated 2026-11-05
NCT07441694
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Trial Treatment · Phase 1 · Incyte Corporation
Seoul National University Hospital, Jongno-gu, Seoul · The Catholic University of Korea Seoul St. Mary'S Hospital, Seocho-gu, Seoul
Registry updated 2026-10-30
NCT04771130
A Study of BGB-11417 in Participants With Myeloid Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Samsung Medical Center, GangnamGu · Severance Hospital Yonsei University Health System, SeodaemunGu
Registry updated 2026-09-14
NCT05980806
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Trial Treatment · Phase 2 · Karyopharm Therapeutics Inc
Pusan National University Hospital, Busan · Seoul St. Mary's Hospital, The Catholic University of Korea, Seocho · Seoul National University Hospital, Seoul · Severance hospital, Seoul
Registry updated 2026-02-12
NCT05037760
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Trial Treatment · Phase 2 · Takeda
Gachon University Gil Medical Center, Incheon · Seoul St. Marys Hospital, The Catholic University of Korea, Seoul · Samsung Medical Center, Seoul · SoonChunHyang University Seoul Hospital, Seoul
Registry updated 2026-02-05
NCT06479135
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Trial Treatment · Phase 3 · Kartos Therapeutics, Inc.
Pusan National University Hospital, Busan · Inje University Busan Paik Hospital, Busan · Keimyung University - Dongsan Medical Center, Daegu · Kyungpook National University Hospital, Daegu · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Soon Chun Hyang University Hospital Seoul, Seoul
Registry updated 2025-09-25
NCT06073847
A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis
Research · Bristol-Myers Squibb
Bristol-Myers Squibb YH, Seoul · Seoul · Novotech Laboratory Korea Co., Ltd., Seoul
Registry updated 2024-11-06

All Myeloproliferative neoplasms trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error